Comparable stake leader
Jacob D. Cohen
SEC ownership of MANGOCEUTICALS, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001938046.
Disclosed value leader
Jacob D. Cohen
Comparable rows
2/28
Latest evidence
28 Jul 2026
- Public ticker
- MGRX on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Jacob D. Cohen
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
2 of 28
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Jacob D. Cohen
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
28 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001938046
- Issuer location
- Dallas, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of MANGOCEUTICALS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jacob D. Cohen
Disclosed value leader
Jacob D. Cohen
Comparable rows
2/28
Latest evidence
28 Jul 2026
13D/G
3/4/5
13F
Lead comparable stake: 22%
26 rows are not safely comparable across share classes.
13D/G row: Jacob D. Cohen
Showing 1-8 of 28 holder rows.
Quick read
Jacob D. Cohen leads the comparable SEC ownership view at 22%.
2 of 28 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jacob D. Cohen's linked filing trail.
Comparable ownership
Top 2
Jacob D. Cohen
22%
GREENFIELD INVESTMENTS LTD.
14%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 28 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jacob D. Cohen |
13D/G
3/4/5
Chief Executive Officer, Director, 10%+ Owner
|
22%
Reported 13D/G
· 09 Mar 2026
|
$1,721,300
4,098,333 shares
|
+$862,670 | 09 Mar 2026 |
| GREENFIELD INVESTMENTS LTD. |
13D/G
|
14%
Reported 13D/G
· 13 Dec 2024
|
$916,700
515,000 shares
|
$0 | 13 Dec 2024 |
| Tiger Cub Trust |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,388,100
3,305,000 shares
|
— | 30 Sep 2025 |
| Jonathan Arango |
3/4/5
President, COO and Secretary, Director
|
—
denominator unverified
|
$1,000,000
1,000,000 shares
|
— | 20 Mar 2023 |
| Dr. Kenny Myers |
3/4/5
Director
|
—
denominator unverified
|
$232,333
136,667 shares
|
— | 09 Sep 2025 |
| Lorraine Pamela D'Alessio |
3/4/5
Director
|
—
denominator unverified
|
$232,333
136,667 shares
|
— | 09 Sep 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$128,806
338,964 shares
|
— | 30 Jun 2026 |
| Eugene M. Johnston |
3/4/5
CFO
|
—
denominator unverified
|
$92,400
220,000 shares
|
-$21,139 | 28 Jul 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$174,014.
Buys
$0
Insiders: 0
Sells
$174,014
Insiders: 2
Net
-$174,014
Shares: -143,333
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 143,333
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 143,333 | $0 | $174,014 | -$174,014 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-9 of 9 reporting-owner rows connected to MANGOCEUTICALS, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
9
Largest Forms 3/4/5 holder
Jacob D. Cohen
Net 12M change
-$174.01K
Full value: -$174,014 · USD · 12-month changeLatest report
28 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jacob D. Cohen | Chief Executive Officer, Director, 10%+ Owner | $1,388,100 | Mixed | 16 Mar 2026 | ||
| Tiger Cub Trust | 10%+ Owner | $1,388,100 | Mixed | 30 Sep 2025 | ||
| Jonathan Arango | President, COO and Secretary, Director | $1,000,000 | Mixed | 20 Mar 2023 | ||
| Lorraine Pamela D'Alessio | Director | $232,333 | Mixed | 09 Sep 2025 | ||
| Dr. Kenny Myers | Director | $232,333 | Mixed | 09 Sep 2025 | ||
| Eugene M. Johnston | Cfo | $92,400 | -$21,139 | -19% | Mixed | 28 Jul 2026 |
| Amanda Elizabeth Hammer | Chief Operating Officer | $75,000 | Mixed | 03 Jun 2024 | ||
| Alex P. Hamilton | Director | $42,700 | -$152,875 | -78% | Mixed | 28 Jul 2026 |
| Antonios Isaac | President, Director | $0 | Mixed | 10 Apr 2025 |
Recent insider transactions for MANGOCEUTICALS, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Cohen Jacob D. | MGRX | Common Stock | Gift | 153.3% | 2,000,000 | 3,305,000 | 11 Aug 2026 | Direct | ||
| Jacob D. Cohen | MGRX | Common Stock | Gift | 153.3% | 2,000,000 | 3,305,000 | 11 Aug 2026 | Direct | ||
| Cohen Jacob D. | MGRX | Common Stock | Gift | -100% | -2,000,000 | 0 | 11 Aug 2026 | Direct | ||
| Jacob D. Cohen | MGRX | Common Stock | Gift | -100% | -2,000,000 | 0 | 11 Aug 2026 | Direct | ||
| Cohen Jacob D. | MGRX | Common Stock | Award | 2,000,000 | 2,000,000 | 28 Jul 2026 | Direct | |||
| Jacob D. Cohen | MGRX | Common Stock | Award | 2,000,000 | 2,000,000 | 28 Jul 2026 | Direct | |||
| Eugene M. Johnston | MGRX | Common Stock | Award | 83.3% | 100,000 | 220,000 | 28 Jul 2026 | Direct | ||
| Alex P. Hamilton | MGRX | Common Stock | Award | 5998.8% | 100,000 | 101,667 | 28 Jul 2026 | Direct | ||
| Jacob D. Cohen | MGRX | Stock Option (right to buy) | Award | 2,133,333 | 2,000,000 | 16 Mar 2026 | Direct | |||
| Jacob D. Cohen | MGRX | Stock Option (right to buy) | Disposed to Issuer | -100% | -2,133,333 | 0 | 16 Mar 2026 | Direct | ||
| Cohen Jacob D. | MGRX | Convertible Promissory Note | Other | 0 | $0 | 19 Dec 2025 | Direct | |||
| Jacob D. Cohen | MGRX | Convertible Promissory Note | Other | 0 | $0 | 19 Dec 2025 | Direct | |||
| Eugene M. Johnston | MGRX | Common Stock | Sale | -2.7% | -$3,884 | $1.17 | -3,333 | 120,000 | 15 Dec 2025 | Direct |
| Eugene M. Johnston | MGRX | Common Stock | Sale | -3.9% | -$5,975 | $1.20 | -5,000 | 123,333 | 09 Dec 2025 | Direct |
| Eugene M. Johnston | MGRX | Common Stock | Sale | -7.23% | -$11,280 | $1.13 | -10,000 | 128,333 | 05 Dec 2025 | Direct |
| Alex P. Hamilton | MGRX | Common Stock | Sale | -97.4% | -$152,875 | $1.22 | -125,000 | 3,334 | 19 Nov 2025 | Direct |
* marks a reported price that did not pass the local price check.